EDHO2022

Mickey Koh

ISBT Regional Director Europe, Cellular Therapies Working Party Past Chair, Director, Stem Cell Transplantation at St George's hospital and Medical School, London, UK

Regional Director Europe

Have you got a question for Mickey? Fill out the form below. 

Denese Marks

ISBT BC WP Chair, Associate Professor, University of Sydney, Australia; Australian Red Cross LifeBlood Service

Thierry Burnouf

Cellular Therapies Treasurer, Vice-Dean, Taipei Medical University, Taiwan

Thierry Burnouf, PhD, is Vice-Dean, Professor, and Director of the International PhD Program in Biomedical Engineering at Taipei Medical University, Taiwan. He previously served as Director of Research and Development and Production at the Regional Blood Transfusion Center in Lille, France, and as Scientific Director at LFB (Laboratoire Français du Fractionnement et des Biotechnologies).

He has played a key role in the development and industrial implementation of plasma fractionation technologies and viral inactivation and removal procedures, supporting both domestic and contract plasma fractionation programs worldwide. Dr Burnouf has acted as a WHO consultant and temporary advisor, contributing to major international guidelines on viral safety, GMP in blood establishments, and plasma fractionation.

He is a member of ISBT Working Parties on Cellular Therapies and Global Blood Safety and has authored over 230 scientific publications. His current research focuses on bioengineering virally-safe platelet growth factor preparations and extracellular vesicles for regenerative medicine and cell therapy.

Thierry Burnouf received the ISBT Presidential Award in 2024.

Birgit Gathof

Director, Transfusion Medicine Unit of the University Hospital

Former ISBT Regional Director Europe (2018-2022)

Birgit Gathof is director of the Transfusion Medicine Unit of the University Hospital of Cologne, Germany. Experience of nine years internal medicine and over 20 years in blood transfusion. Birgit is active in the ISBT Working Party “Clinical transfusion” and co-chair of its subgroup responsible for Patient Blood Management (PBM) educational material. She is also chair of the WP “Hämotherapie” of the German DGTI. Active in the promotion of PBM in the setting of long standing quality assurance in hemotherapy by teaching and the respective explanation and revision of relevant guidelines. Her scientific interests include different aspects of hemotherapy with respect to donor and recipient and product safety and development (pathogenreduction).